TREATMENT OPTIONS IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - A WAGER ON THE FUTURE - A REVIEW

被引：27

作者：

DROZ, JP ^{[1
]}

VANOOSTEROM, AT ^{[1
]}

机构：

[1] UNIV ZIEKENHUIS ANTWERPEN,DEPT ONCOL,ANTWERP,BELGIUM

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 07期

关键词：

D O I：

10.1016/S0959-8049(05)80220-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1038 / 1044

页数：7

共 50 条

[21] SURVEILLANCE OR ETOPOSIDE-CONTAINING COMBINATION CHEMOTHERAPY FOR STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS (NSGCTT)
COLLS, BM
BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1276 - 1276
[22] PREDICTING RELAPSE IN STAGE-I NONSEMINOTAMOUS GERM-CELL TUMORS OF THE TESTIS
DEWAR, JM
SPAGNOLO, DV
JAMROZIK, KD
VANHAZEL, GA
BYRNE, MJ
LANCET, 1987, 1 (8530): : 454 - 454
[23] EXPECTANT THERAPY FOR CLINICAL STAGE-A NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - NO
LIESKOVSKY, G
SKINNER, DG
WORLD JOURNAL OF UROLOGY, 1984, 2 (01) : 53 - 56
[24] ROLE OF PRIMARY CHEMOTHERAPY IN STAGE-I AND LOW-VOLUME STAGE-II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS
STERNBERG, CN
UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (01) : 93 - 109
[25] TREATMENT DECISION FOR STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS BASED ON THE RISK FACTOR VASCULAR INVASION
HOELTL, W
PONT, J
KOSAK, D
HONETZ, N
MARBERGER, M
BRITISH JOURNAL OF UROLOGY, 1992, 69 (01): : 83 - 87
[26] OBSERVATION AFTER ORCHIECTOMY IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMOR OF TESTIS - MAYO CLINIC EXPERIENCE
PATEL, SR
RICHARDSON, RL
KVOLS, L
ZINCKE, H
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 379 - 381
[27] RESULTS OF THE SURVEILLANCE POLICY OF STAGE-I NONSEMINOMATOUS GERM-CELL TESTICULAR-TUMORS
COLLS, BM
HARVEY, VJ
SKELTON, L
THOMPSON, PI
DADY, PJ
FORGESON, GV
PEREZ, DJ
BRITISH JOURNAL OF UROLOGY, 1992, 70 (04): : 423 - 428
[28] DISEASE RELAPSE IN PATIENTS WITH STAGE-I NONSEMINOMATOUS GERM-CELL TUMOR OF THE TESTIS ON ACTIVE SURVEILLANCE
THOMPSON, PI
NIXON, J
HARVEY, VJ
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) : 1597 - 1603
[29] TREATMENT FOR STAGE-I-II NONSEMINOMATOUS GERM-CELL TUMOR OF THE TESTIS
SAKALO, VS
KLIMENKO, IA
ZAPARIN, VK
YAREMKO, VN
VOPROSY ONKOLOGII, 1988, 34 (05) : 608 - 612
[30] SURVEILLANCE OR ETOPOSIDE-CONTAINING COMBINATION CHEMOTHERAPY FOR STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS (NSGCTT) - REPLY
CULLEN, MH
BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1277 - 1277

← 1 2 3 4 5 →